antigenics inc

Biotechnology company Antigenics Inc. on Monday named former Sanofi-Aventis executive Timothy Rothwell to its board of directors.

Antigenics Inc. (Nasdaq: AGEN) 89.6% HIGHER; is continuing its recent momentum run after announcing positive Oncophage interim survival data at ASCO this weekend.

Notably, shares have risen more than 220% since the news hit. TiVo Inc. (Nasdaq: TIVO) 46.9% HIGHER; a Judge upheld Tivo patents and said Echostar (Nasdaq: SATS) is infringing on them, according to Bloomberg.

Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) 98.6% HIGHER; At ASCO yesterday, Keryx announced data on the clinical activity of KRX-0401 (perifosine), the Company's Akt-inhibitor for cancer, in combination with capecitabine as a treatment for advanced colon cancer. Click here for the full report.